This large pharmaceutical company was facing the following challenges: - Solidify the network as the infrastructure across which their intellectual property is developed, quality-assured and delivered to market while enhancing global network security, speed and agility. - Better manage the process of merging acquired companies into the main corporate network. - Reduce business risk by implementing role-based access, full change tracking and the replacement of fragmented, spreadsheet-based management of IPAM data. - Increase the ROI on network-associated IT investments, such as virtualization, cloud and SDN.
The customer deployed BlueCat across the corporate network as the global IPAM repository, controlling both Microsoft and BlueCat DNS and DHCP. In order to manage project risks, BlueCat used a phased roll-out and subsequent environment upgrades.
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.